• Home
  • About
  • Resources for States
    • Issue Briefs
    • Templates & Toolkits
    • Webinars
  • Expert Perspectives
  • Contact
  • COVID-19
  • Health Equity
  • Unwinding

COVID-19 Resources for States

  • Search

  • Topic:

  • Resource Type

  • Source

State Health and Value Strategies (SHVS), in partnership with Manatt Health, Georgetown’s Center on Health Insurance Reforms (CHIR), State Health Access Data Assistance Center (SHADAC), Bailit Health, and GMMB developed this resource page to serve as an accessible “one-stop” source of COVID-19 information for states. This resource is designed to support states seeking to make coverage and essential services available to all of their residents, especially high-risk and vulnerable people, during the COVID-19 pandemic. SHVS will update this page frequently with new resources as they become available.

If you have materials you are willing to share with other states through this page, or if there are topics of particular concern that you would like addressed, please contact SHVS.

Filter By:

  • Search

  • Topic:

  • Resource Type

  • Source

Federal Statute and Guidance Covid-19

FAQs: Provision of Methadone and Buprenorphine for the Treatment of Opioid Use Disorder in the COVID-19 Emergency

Substance Abuse and Mental health Services Administration (SAMHSA)

This FAQ answers common provider questions regarding the provision of methadone and buprenorphin, including through the use of telehealth, for the treatment of opioid disorder during the COVID-19 crisis.

Read More
Date Created: Apr 27, 2020
State Examples and Models Covid-19

Telehealth Resources during COVID-19 Crisis for Medicaid Providers

North Carolina

North Carolina website cataloging guidance on telehealth expansion during COVID-19, including recent policies related to enhanced behavioral health services, optometry services, postpartum care visits, and even self-measured blood pressure monitoring.

Read More
Date Created: Apr 27, 2020
State Examples and Models Covid-19

Medicaid Provider Memo: Provider Flexibilities Related to COVID-19

Virginia

Medicaid memo to providers summarizing changes to program requirements, including expansion of telehealth coverage, provider licensure, and prior authorization for services, during the COVID-19 crisis. Content on behavioral health was updated in a subsequent memo.

Read More
Date Created: Apr 17, 2020
State Examples and Models Covid-19

Medicaid Provider Memo: Provider Flexibilities Related to COVID-19: Clarifications and Changes to Behavioral Health and ARTS Provider Flexibilities Only

Virginia

This memo clarifies a section of the earlier Medicaid provider memo on flexibilities offered to providers of behavioral health and addiction and recovery treatment.

Read More
Date Created: Apr 17, 2020
State Examples and Models Covid-19

Program and Billing Guidance for Adult Continuing Day Treatment Programs RegardingEmergency Response to COVID-19

New York

Guidance from New York State Office of Mental Health on adult Continuing Day Treatment (CDT) program expectations, changes in documentation requirements during the disaster emergency period, and reduction or elimination of minimum billing requirements.

Read More
Date Created: Apr 15, 2020
State Examples and Models Covid-19

Program and Billing Guidance for Assertive Community Treatment Programs RegardingEmergency Response to COVID-19

New York

Guidance from New York State Office of Mental Health on Assertive Communty Treatment (ACT) program expectations, changes in documentation requirements during the disaster emergency period, and the reduction or elimination of minimum billing requirements.

Read More
Date Created: Apr 15, 2020
Federal Statute and Guidance Covid-19

Novel Coronavirus (COVID-19) Frequently Asked Questions

Health Resources & Services Administration (HRSA)

FAQs include HRSA’s guidance for health centers related to COVID-19, which is updated on an ongoing basis. 4/7 updates to FAQs include guidance on infection control/prevention for health centers, health center obligations for paid sick leave/other benefits for staff, liability protections for volunteer providers, permissible adjustments to operating hours, telehealth, and scope of practice.

Read More
Date Created: Apr 13, 2020
Federal Statute and Guidance Covid-19

Medicare and Medicaid Programs; Policy and Regulatory Revisions in Response to the COVID-19 Public Health Emergency

CMS

CMS released an interim final rule with comment period that proposes several changes to the Medicaid and Medicare programs. For the Medicaid program, the rule amends health home regulations by allowing other licensed practitioners to order home health services, without physician sign-off.

Read More
Date Created: Apr 9, 2020
State Examples and Models Covid-19

Coronavirus Information

Ohio

This comprehensive resource page on COVID-19 guidance includes multiple funding opportunities to support telehealth for behavioral health services, naloxone distribution, and Opioid Treatment Program facilities.

Read More
Date Created: Apr 9, 2020
State Examples and Models Covid-19

COVID Letter to LME-MCOs

North Carolina

This letter to behavioral health managed care plans outlines efforts from NC DHHS to provide flexible funding to stabilize providers and respond to the changing needs of consumers.

Read More
Date Created: Apr 9, 2020
Federal Statute and Guidance Covid-19

Use of Telephone Evaluations to Initiate Buprenorphine Prescribing

DEA

This guidance allows practitioners further flexibility in prescribing and dispensing buprenorphine to new and existing patients with opioid use disorder via telephone without examination in person or via telemedicine.

Read More
Date Created: Apr 9, 2020
Federal Statute and Guidance Covid-19

Exemption Allowing Alternate Delivery Methods for OTPs

Drug Enforcement Administration (DEA)

This guidance allows OTPs to make “door stop” deliveries for medications for opioid use disorder in a lock-box for patients under quarantine.

Read More
Date Created: Apr 9, 2020
Federal Statute and Guidance Covid-19

Drug Enforcement Administration (DEA)

Drug Enforcement Administration (DEA)

This guidance allows OTPs to make “door stop” deliveries for medications for opioid use disorder in a lock-box for patients under quarantine.

Read More
Date Created: Apr 9, 2020
Federal Statute and Guidance Covid-19

Exception to Regulations Emergency Oral CII Prescription

Drug Enforcement Administration (DEA)

This guidance allows prescribers and practitoners to issue time limited prescriptions of schedule II drugs via oral communication (e.g., telephone) under limited circumstances.

Read More
Date Created: Apr 9, 2020
Federal Statute and Guidance Covid-19

Exception to Separate Registration Requirements Across State Lines

Drug Enforcement Administration (DEA)

This guidance allows practitioners to dispense schedule II-IV drugs (including methadone, buprenorphine and opioids) not only in their home states but also in states with which their home stateshave reciprocity.

Read More
Date Created: Apr 9, 2020
State Examples and Models Covid-19

Massachusetts to Allow Pharmacists to Administer Opioid Medication

Massachusetts

This order allows pharmacists and pharmacy interns to administer methadone and buprenorphine for the treatment of opioid use disorder.

Read More
Date Created: Apr 9, 2020
Analysis Covid-19

Summary of Healthcare Provisions of COVID-19 Stimulus Package #3 (CARES Act)

Manatt Health

Read More
Date Created: Apr 9, 2020
State Examples and Models Covid-19

Alert Regarding COVID-19 for Opioid Treatment Programs

Massachusetts

This memo provides interim guidance to assist Opioid Treatment Programs with providing medications to patients, aligning state policy with federal take home exceptions of 14 and 28 days.

Read More
Date Created: Apr 9, 2020
State Examples and Models Covid-19

DHCS COVID-19 Frequently Asked Questions: Narcotic Treatment Programs (NTPs)

California

This FAQ provides guidance to narcotic treatment programs, including information on services that may be provided by telehealth.

Read More
Date Created: Apr 9, 2020
State Examples and Models Covid-19

MassHealth Coverage and Reimbursement Policy for Services Related to Coronavirus Disease 2019

Massachusetts

MA developed a managed care plan bulletin that outlines requirement’s for coverage and billing related to COVID-19.

Read More
Date Created: Apr 9, 2020
State Examples and Models Covid-19

Frequently Asked Questions: Coronavirus Disease 2019 (COVID-19) and Behavioral Health Administration Partners

Maryland

This FAQ includes guidance for behavioral health providers, partners, and the greater community to develop coordinated prevention and response plans for COVID-19.

Read More
Date Created: Apr 9, 2020
State Examples and Models Covid-19

DHCS COVID‑19 Response

California

Read More
Date Created: Apr 9, 2020
State Templates and Toolkits Covid-19

1115 Application Process

CMS

This page includes guidance and a template for COVID-19 1115 waiver demonstrations.

Read More
Date Created: Apr 8, 2020
No more results

Filter By:

  • Search

  • Topic:

  • Resource Type

  • Source

Privacy Policy
Terms of Use

© 2019 State Health and Value Strategies is a program of the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Stay in Touch

Subscribe to periodic email updates.